论文部分内容阅读
2007年6月,中国著名的糖尿病专家们会聚北京举行座谈,讨论了在临床工作中进一步促进降糖达标的重要性和几点措施,特别是对于新型的氨基酸类降糖药物那格列奈(唐力~(?))在降糖达标中的地位进行了讨论。与会专家有:潘长玉教授,陈家伟教授,傅祖植教授,纪立农教授,陆菊明教授,朱大龙教授,郭晓蕙教授,洪天配教授,姬秋和教授,彭永德教授等。现将会议讨论的主要内容摘录如下:
In June 2007, well-known Chinese diabetes experts gathered in Beijing to hold a discussion to discuss the importance and measures of further promoting hypoglycemic compliance in clinical work, especially for the new amino acid hypoglycemic drugs nateglinide ( Tang Li ~ (?)) In the hypoglycemic status of the standard were discussed. The participating experts include Professor Pan Changyu, Professor Chen Jiawei, Professor Fu Zuzhi, Professor Ji Lixin, Professor Lu Juming, Professor Zhu Dalong, Professor Guo Xiaohui, Professor Hong Tianpei, Professor Ji Qiuhe and Professor Peng Yongde. The main contents of the meeting are now summarized as follows: